Affineon Health vs Droxi (2026)
Two agents working the ambulatory inbox from inside the record system, scoped narrowly and honestly, and the difference is what each reads before it acts. Droxi reads every inbound item against the patient's full record, which is the design that matters when the urgent complaint is buried in a routine message, and it covers laboratory results, refills and clinical documents for primary care. Affineon covers laboratory result disposition and prescription renewals, and publishes a complete price ladder on its own site, which almost nothing in healthcare AI does. Neither names a model, publishes an accuracy figure, or reports what proportion of its drafts clinicians send unedited. That last number is the one that decides whether either product saves work or moves it, and both should be asked for it before a pilot rather than after.
- It reads each inbound item against the patient's full record rather than against the message alone, which is what separates triage from keyword routing when an urgent complaint arrives inside a routine looking message.
- It runs natively inside the record system with no separate login or parallel application, and it is listed on a major record system marketplace rather than only claiming integration.
- Scope is stated plainly as primary care and three item types, laboratory results, refills and clinical documents, which is an honest boundary rather than a claim to work the whole inbox.
- The two workflows it covers are the highest volume ones in most ambulatory practices, and it publishes what it costs, with a complete price ladder on its own site.
- It publishes an account of its own oversight design rather than describing it generically, which is more than most of this segment offers.
- A displayed attestation badge and a stated compliance position, which is more security signalling than the alternative publishes, even though neither publishes an agreement.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Affineon Health and Droxi are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Affineon Health | Droxi |
|---|---|---|
| Primary category | Clinical Inbox & Messaging AI | Clinical Inbox & Messaging AI |
| Headquarters | Denver, Colorado | Tel Aviv, Israel |
| Website | affineon.com | droxi.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Affineon Health its top capability grade on AI Centrality and Commercial Transparency. Set against Droxi, Affineon Health grades higher on Security Certifications and Trust Center and Commercial Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Droxi its top capability grade on AI Centrality. Set against Affineon Health, Droxi grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Affineon Health or Droxi?
On the axes where the AI Health Index separates them, Affineon Health grades higher on Security Certifications and Trust Center and Commercial Transparency, and Droxi grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Droxi leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Affineon Health and Droxi differ most?
The widest separation the AI Health Index records between Affineon Health and Droxi is on Commercial Transparency, where Affineon Health grades A and Droxi grades C. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.
Where do Affineon Health and Droxi grade the same?
The AI Health Index grades Affineon Health and Droxi the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Affineon Health and Droxi not disclosed?
At the last review, at least one of Affineon Health and Droxi published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Inbox & Messaging AI page.
Neither vendor names a model, publishes a model card, states whether foundation models are first or third party, or discloses an accuracy figure, and neither publishes subgroup or performance variation analysis. That gap matters more in this category than in most: the failure is mistriage, an urgent clinical signal sitting inside a routine looking message, and neither vendor publishes how often that happens or what proportion of generated drafts clinicians send unedited.
Neither publishes business associate agreement terms. Affineon's privacy policy is a generic marketing website policy predating the product; Droxi's only security claim is that it is compliant with enterprise grade security, which is not an attestation. All evidence on both records is vendor assembled.